What is Biomedical Research Models?
Operating as a premier preclinical contract research organization, Biomedical Research Models provides essential services including efficacy, pharmacokinetics, pharmacodynamics, and ADME studies. Based in Worcester, Massachusetts, the firm distinguishes itself through a highly personalized approach to project management and a robust portfolio of both rodent and large animal models. As an AAALAC accredited and USDA registered facility, the company maintains the highest standards of animal welfare and scientific integrity. Its integration with global networks allows for seamless execution of both non-GLP and GLP studies, positioning it as a vital partner for innovators navigating the early stages of drug discovery and development.
How much funding has Biomedical Research Models raised?
Biomedical Research Models has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Biomedical Research Models
PPP
Public-Private Partnership
What's next for Biomedical Research Models?
With this major strategic investment, Biomedical Research Models is poised to accelerate its operational scaling and enhance its technical capabilities. The firm is expected to focus on expanding its laboratory capacity and investing in advanced diagnostic technologies to meet the evolving needs of its global client base. By prioritizing expedited project start times and dedicated resourcing, the company aims to reduce the time-to-market for novel therapeutics. Future growth will likely center on deepening its expertise in specialized therapeutic areas, further cementing its reputation as a cornerstone of the preclinical research landscape.
See full Biomedical Research Models company page
